within Pharmacolibrary.Drugs.ATC.C;

model C01AA07
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 5e-05,
    adminDuration  = 600,
    adminMass      = 0.4 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0004,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.0011,
    k12             = 0.03,
    k21             = 0.03
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C01AA07</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Deslanoside is a cardiac glycoside formerly used in the treatment of heart failure and certain cardiac arrhythmias, similar to digitoxin and digoxin. It acts by inhibiting the Na+/K+ ATPase pump, leading to increased intracellular calcium and enhanced cardiac contractility. Currently, deslanoside is rarely used, having been largely replaced by other glycosides in clinical practice.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for deslanoside in healthy adults, based on literature review and pharmacological similarity to other cardiac glycosides.</p><h4>References</h4><ol><li><p>Bakke, OM, et al., &amp; Lien, E (1981). Pharmacokinetics and serum concentration--effect relationship of intravenous deslanoside. <i>Journal of cardiovascular pharmacology</i> 3(5) 1015–1025. DOI:<a href=&quot;https://doi.org/10.1097/00005344-198109000-00012&quot;>10.1097/00005344-198109000-00012</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6168847/&quot;>https://pubmed.ncbi.nlm.nih.gov/6168847</a></p></li><li><p>Tada, A, et al., &amp; Furuta, S (1982). [Pharmacokinetics of deslanoside in man]. <i>Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan</i> 102(11) 1061–1066. DOI:<a href=&quot;https://doi.org/10.1248/yakushi1947.102.11_1061&quot;>10.1248/yakushi1947.102.11_1061</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7182446/&quot;>https://pubmed.ncbi.nlm.nih.gov/7182446</a></p></li><li><p>Doherty, JE (1985). Clinical use of digitalis glycosides. An update. <i>Cardiology</i> 72(5-6) 225–254. DOI:<a href=&quot;https://doi.org/10.1159/000173883&quot;>10.1159/000173883</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2866838/&quot;>https://pubmed.ncbi.nlm.nih.gov/2866838</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C01AA07;
